Does LENVATINIB Cause Haemoptysis? 174 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 174 reports of Haemoptysis have been filed in association with LENVATINIB (Lenvima). This represents 0.5% of all adverse event reports for LENVATINIB.
174
Reports of Haemoptysis with LENVATINIB
0.5%
of all LENVATINIB reports
46
Deaths
124
Hospitalizations
How Dangerous Is Haemoptysis From LENVATINIB?
Of the 174 reports, 46 (26.4%) resulted in death, 124 (71.3%) required hospitalization, and 16 (9.2%) were considered life-threatening.
Is Haemoptysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENVATINIB. However, 174 reports have been filed with the FAERS database.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Haemoptysis?
RIVAROXABAN (1,961)
ASPIRIN (1,255)
APIXABAN (846)
TREPROSTINIL (838)
ALBUTEROL (652)
CLOPIDOGREL BISULFATE (643)
PREDNISONE (618)
WARFARIN (555)
ADALIMUMAB (472)
TIOTROPIUM (462)
Which LENVATINIB Alternatives Have Lower Haemoptysis Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE